GMIT has a new state of the art Medical Imaging Suite to add to the expanding range of resources on offer for medtech researchers.
The installation of the Philips Azurion 7 M20 digital fluoroscope is the latest expansion of the Medical and Engineering Technologies (MET) Gateway at GMIT.
The fluoroscope, which represents an €840,000 investment by Enterprise Ireland, can be used for a variety of vascular, non-vascular, cardiovascular and neuro applications.
With its extremely high resolution and large field of view, it captures images that allow researchers to examine minute details and vessels in the body with clarity.
Dr Rick Officer, Vice President for Research and Innovation at GMIT, says: “This facility compliments the MET Gateway’s existing expertise in medical imaging, anatomical modelling and physiological replication.
“Our state-of-the-art medical testing facility supports the development of next generation medical technologies.”
It will enable industry, research and academic partners to design, test and demonstrate features of their new technologies on equipment not readily available outside of clinical environments”.
He adds “GMIT has established strong ties with the medtech industry in Ireland and together we aim to provide safer therapies to improve health outcomes for patients”.
The Medical Imaging Suite can also be used for training of clinicians, staff and students in new imaging technologies and interpreting medical images, as well its function in demonstrating and evaluating new medical devices.
MET Gateway Manager Sharon White said that they are delighted to have this state of the art resource to share with industry partners.
“It will enable us to continue to grow and expand our collaboration with the MedTech sector and support them in the development of cutting-edge medical technologies”.
A virtual launch webinar for the new Medical Imaging Suite will take place on Thursday, May 27 at 11am. Register for your place here.
The Enterprise Ireland Medical and Engineering Technologies (MET) Gateway is an interdisciplinary research centre, dedicated to supporting research, development and innovation activities in the MedTech, LifeSciences and Engineering sectors.
It offers industry bodies easier access to the academic resources and facilities within GMIT in order to help companies develop products for the market.
Programme Manager Mark Whelan at Enterprise Ireland, said “This state-of-the-art facility is truly world class and will enable the full range of companies from new startups to the established medical device companies, both locally and nationally to develop new and improved devices at an accelerated rate.”
He added that it will help to keep Irish companies at the forefront of the medtech industry.
